Galapagos NV

NasdaqGS:GLPG Stock Report

Market Cap: US$2.2b

Galapagos Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Henry Gosebruch

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation

Dec 22

Disount To Net Cash For A Promising CAR-T Company

Feb 20

Galapagos Struggles To Carve A Path In A Crowded CAR-T Therapy Market

Dec 14

Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond

Aug 23

Galapagos: Pipeline Still Progressing Despite Financial Volatility

Mar 07

Galapagos: Trading At Discount To Cash With A Fast-Growing Marketed Product

Oct 10

EMA panel approves amending label for Galapagos' Jyseleca on testicular function effects

Oct 03

Galapagos stock dips after Jefferies slashes rating citing challenges ahead

Jul 25

Galapagos: Can The Company Turn Around?

May 19

Galapagos: A History Of Disruptive Failures

Feb 22

Galapagos: The Investment Thesis Is More Appealing Than Ever

Dec 02

CEO

Henry Gosebruch

less than a year
Tenure

Mr. Henry Gosebruch is CEO & Executive Director of Galapagos NV from May 13, 2025. He serves as Founding CEO of SpinCo since April 21, 2025.

Leadership Team

NamePositionTenureCompensationOwnership
Henry Gosebruch
CEO & Executive Directorless than a yearno datano data
Aaron Cox
Chief Financial Officerless than a yearno datano data
Glenn Schulman
Head of Investor Relationsno datano datano data
Fred Blakeslee
Executive VP & General Counselless than a yearno datano data
Marieke Vermeersch
Head of Corporate Communicationno datano datano data
Annelies Missotten
Executive VP & Chief Human Resources Officerno datano datano data
Ellen Aar
Head of Developmentno datano datano data
Patrik Ringblom
Head of Strategy & US Lead2.3yrsno datano data
Jeevan Shetty
Head of Clinical Development Oncologyno datano datano data
Ruiz Astigarraga
Head of Manufacturing Cell Therapyno datano datano data
John Mellors
Head of Cell & Antibody Therapy Discoveryno datano datano data
Robert Hughes
Global Head of Technical Operations2yrsno datano data
0.7yrs
Average Tenure
52yo
Average Age

Experienced Management: GLPG's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Henry Gosebruch
CEO & Executive Directorless than a yearno datano data
Neil Johnston
Non-Executive Independent Directorless than a yearno datano data
Jerome Contamine
Lead Independent Non-Executive Director & Chairman3.8yrs€184.60k0.0033%
$ 72.9k
Dawn Svoronos
Non-Executive Independent Directorless than a yearno datano data
Linda Higgins
Non-Executive Non-Independent Director6.3yrsno datano data
Oleg Nodelman
Non-Executive Non-Independent Director1.3yrsno datano data
Jane Griffiths
Non-Executive Independent Directorless than a yearno datano data
Devang Bhuva
Non-Executive Non-Independent Directorless than a yearno datano data
0.6yrs
Average Tenure
65.5yo
Average Age

Experienced Board: GLPG's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/18 05:18
End of Day Share Price 2026/01/16 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Galapagos NV is covered by 30 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xue ChenBarclays
Emily FieldBarclays
Patrick TrucchioBerenberg